ENVB Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Valuation Metrics

The current forward P/E ratio for Enveric Biosciences Inc (ENVB.O) is -0.36, compared to its 5-year average forward P/E of -1.39. For a more detailed relative valuation and DCF analysis to assess Enveric Biosciences Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-1.39

Current PE

-0.36

Overvalued PE

0.43

Undervalued PE

-3.21

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

0.06

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

0.31

Undervalued EV/EBITDA

-0.20

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

0.00

Current PS

0.00

Overvalued PS

0.00

Undervalued PS

0.00

Financials

Annual

Quarterly

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

FCF Margin - %

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

ENVB News & Events

Events Timeline

No data

News

3.5

2025-12-29Newsfilter

Enveric Secures U.S. Patent Expanding Neuropsychiatric Drug Development

5.0

2025-12-15Newsfilter

ENvue Appoints David Johnson as Chairman to Drive Feeding Tube Technology Advancement

8.5

2025-12-12Newsfilter

Enveric Biosciences Exercises 426,390 Warrants at $7.05 Each, Raising $3.1 Million

People Also Watch

Frequently Asked Questions

What is Enveric Biosciences Inc (ENVB) stock price today?

The current price of ENVB is 3.96 USD — it has decreased -2.94 % in the last trading day.

What is Enveric Biosciences Inc (ENVB)'s business?

Enveric Biosciences, Inc. is a biotechnology company. The Company is engaged in the development of neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, and addiction disorders. Leveraging its discovery and development platform, the Psybrary platform, which houses proprietary information on the use and development of existing and novel molecules for specific mental health indications, the Company seeks to develop a robust intellectual property portfolio of drug candidates. Its lead molecule, EB-003, is a neuroplastogen designed to promote neuroplasticity, without inducing hallucinations, in patients suffering from difficult-to-address mental health disorders. The Company is focused on advancing EB-003 towards clinical trials for the treatment of neuropsychiatric disorders while out-licensing other Psybrary platform drug candidates to third-party licensees and advancing non-competitive market strategies for patient care.

What is the price predicton of ENVB Stock?

Wall Street analysts forecast ENVB stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for ENVB is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Enveric Biosciences Inc (ENVB)'s revenue for the last quarter?

Enveric Biosciences Inc revenue for the last quarter amounts to -1.87M USD, decreased -10.04 % YoY.

What is Enveric Biosciences Inc (ENVB)'s earnings per share (EPS) for the last quarter?

Enveric Biosciences Inc. EPS for the last quarter amounts to USD, decreased % YoY.

What changes have occurred in the market's expectations for Enveric Biosciences Inc (ENVB)'s fundamentals?

The market is revising No Change the revenue expectations for Enveric Biosciences, Inc. (ENVB) for FY2025, with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by -53.17%.

How many employees does Enveric Biosciences Inc (ENVB). have?

Enveric Biosciences Inc (ENVB) has 5 emplpoyees as of January 10 2026.

What is Enveric Biosciences Inc (ENVB) market cap?

Today ENVB has the market capitalization of 4.05M USD.